VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q39679945 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241121000315.0
008 241121nneanz||abbn n and d
035 ‎‡a (WKP)Q39679945‏
024 ‎‡a 0000-0001-9966-2335‏ ‎‡2 orcid‏
024 ‎‡a 6603001138‏ ‎‡2 scopus‏
035 ‎‡a (OCoLC)Q39679945‏
100 0 ‎‡a Allan MacKenzie-Graham‏ ‎‡c researcher‏ ‎‡9 en‏
375 ‎‡a 1‏ ‎‡2 iso5218‏
400 0 ‎‡a Allan MacKenzie-Graham‏ ‎‡c wetenschapper‏ ‎‡9 nl‏
400 0 ‎‡a Allan MacKenzie-Graham‏ ‎‡c investigador‏ ‎‡9 ast‏
400 0 ‎‡a Allan MacKenzie-Graham‏ ‎‡c ricercatore‏ ‎‡9 it‏
400 0 ‎‡a Allan MacKenzie-Graham‏ ‎‡c investigador‏ ‎‡9 es‏
670 ‎‡a Author's A multimodal, multidimensional atlas of the C57BL/6J mouse brain‏
670 ‎‡a Author's Bedside to bench to bedside research: Estrogen receptor beta ligand as a candidate neuroprotective treatment for multiple sclerosis‏
670 ‎‡a Author's Bringing CLARITY to gray matter atrophy‏
670 ‎‡a Author's Cerebellar cortical atrophy in experimental autoimmune encephalomyelitis.‏
670 ‎‡a Author's "Classic" myelin basic proteins are expressed in lymphoid tissue macrophages‏
670 ‎‡a Author's Cortical atrophy in experimental autoimmune encephalomyelitis: in vivo imaging‏
670 ‎‡a Author's Disability-Specific Atlases of Gray Matter Loss in Relapsing-Remitting Multiple Sclerosis‏
670 ‎‡a Author's Efficient, Distributed and Interactive Neuroimaging Data Analysis Using the LONI Pipeline‏
670 ‎‡a Author's Enhancing image quality in cleared tissue with adaptive optics‏
670 ‎‡a Author's Estriol combined with glatiramer acetate for women with relapsing-remitting multiple sclerosis: a randomised, placebo-controlled, phase 2 trial.‏
670 ‎‡a Author's Estriol-mediated neuroprotection in multiple sclerosis localized by voxel-based morphometry‏
670 ‎‡a Author's Estrogen treatment prevents gray matter atrophy in experimental autoimmune encephalomyelitis‏
670 ‎‡a Author's Gender differences in autoimmune demyelination in the mouse: implications for multiple sclerosis‏
670 ‎‡a Author's In vivo magnetic resonance images reveal neuroanatomical sex differences through the application of voxel-based morphometry in C57BL/6 mice‏
670 ‎‡a Author's In vivo vs. ex vivo Magnetic Resonance Imaging In Mice‏
670 ‎‡a Author's Inducible nitric oxide synthase and nitric oxide production by oligodendrocytes‏
670 ‎‡a Author's LONI visualization environment‏
670 ‎‡a Author's Mice resistant to experimental autoimmune encephalomyelitis have increased thymic expression of myelin basic protein and increased MBP specific T cell tolerance‏
670 ‎‡a Author's Multimodal, multidimensional models of mouse brain‏
670 ‎‡a Author's Neuroprotective effects of testosterone treatment in men with multiple sclerosis‏
670 ‎‡a Author's Optical Clearing of the Mouse Central Nervous System Using Passive CLARITY‏
670 ‎‡a Author's Provenance in neuroimaging‏
670 ‎‡a Author's Purkinje cell loss in experimental autoimmune encephalomyelitis‏
670 ‎‡a Author's Shifting brain asymmetry: the link between meditation and structural lateralization‏
670 ‎‡a Author's The informatics of a C57BL/6J mouse brain atlas‏
909 ‎‡a (scopus) 6603001138‏ ‎‡9 1‏
909 ‎‡a (orcid) 0000000199662335‏ ‎‡9 1‏
919 ‎‡a miceresistanttoexperimentalautoimmuneencephalomyelitishaveincreasedthymicexpressionofmyelinbasicproteinandincreasedmbpspecifictcelltolerance‏ ‎‡A Mice resistant to experimental autoimmune encephalomyelitis have increased thymic expression of myelin basic protein and increased MBP specific T cell tolerance‏ ‎‡9 1‏
919 ‎‡a provenanceinneuroimaging‏ ‎‡A Provenance in neuroimaging‏ ‎‡9 1‏
919 ‎‡a invivomagneticresonanceimagesrevealneuroanatomicalsexdifferencesthroughtheapplicationofvoxelbasedmorphometryinc57bl6mice‏ ‎‡A In vivo magnetic resonance images reveal neuroanatomical sex differences through the application of voxel-based morphometry in C57BL/6 mice‏ ‎‡9 1‏
919 ‎‡a neuroprotectiveeffectsoftestosteronetreatmentinmenwithmultiplesclerosis‏ ‎‡A Neuroprotective effects of testosterone treatment in men with multiple sclerosis‏ ‎‡9 1‏
919 ‎‡a opticalclearingofthemousecentralnervoussystemusingpassiveclarity‏ ‎‡A Optical Clearing of the Mouse Central Nervous System Using Passive CLARITY‏ ‎‡9 1‏
919 ‎‡a lonivisualizationenvironment‏ ‎‡A LONI visualization environment‏ ‎‡9 1‏
919 ‎‡a shiftingbrainasymmetrythelinkbetweenmeditationandstructurallateralization‏ ‎‡A Shifting brain asymmetry: the link between meditation and structural lateralization‏ ‎‡9 1‏
919 ‎‡a purkinjecelllossinexperimentalautoimmuneencephalomyelitis‏ ‎‡A Purkinje cell loss in experimental autoimmune encephalomyelitis‏ ‎‡9 1‏
919 ‎‡a induciblenitricoxidesynthaseandnitricoxideproductionbyoligodendrocytes‏ ‎‡A Inducible nitric oxide synthase and nitric oxide production by oligodendrocytes‏ ‎‡9 1‏
919 ‎‡a estrogentreatmentpreventsgraymatteratrophyinexperimentalautoimmuneencephalomyelitis‏ ‎‡A Estrogen treatment prevents gray matter atrophy in experimental autoimmune encephalomyelitis‏ ‎‡9 1‏
919 ‎‡a invivovsexvivomagneticresonanceimaginginmice‏ ‎‡A In vivo vs. ex vivo Magnetic Resonance Imaging In Mice‏ ‎‡9 1‏
919 ‎‡a informaticsofac57bl6jmousebrainatlas‏ ‎‡A The informatics of a C57BL/6J mouse brain atlas‏ ‎‡9 1‏
919 ‎‡a multimodalmultidimensionalmodelsofmousebrain‏ ‎‡A Multimodal, multidimensional models of mouse brain‏ ‎‡9 1‏
919 ‎‡a estriolmediatedneuroprotectioninmultiplesclerosislocalizedbyvoxelbasedmorphometry‏ ‎‡A Estriol-mediated neuroprotection in multiple sclerosis localized by voxel-based morphometry‏ ‎‡9 1‏
919 ‎‡a genderdifferencesinautoimmunedemyelinationinthemouseimplicationsformultiplesclerosis‏ ‎‡A Gender differences in autoimmune demyelination in the mouse: implications for multiple sclerosis‏ ‎‡9 1‏
919 ‎‡a estriolcombinedwithglatirameracetateforwomenwithrelapsingremittingmultiplesclerosisarandomisedplacebocontrolledphase2trial‏ ‎‡A Estriol combined with glatiramer acetate for women with relapsing-remitting multiple sclerosis: a randomised, placebo-controlled, phase 2 trial.‏ ‎‡9 1‏
919 ‎‡a efficientdistributedandinteractiveneuroimagingdataanalysisusingthelonipipeline‏ ‎‡A Efficient, Distributed and Interactive Neuroimaging Data Analysis Using the LONI Pipeline‏ ‎‡9 1‏
919 ‎‡a disabilityspecificatlasesofgraymatterlossinrelapsingremittingmultiplesclerosis‏ ‎‡A Disability-Specific Atlases of Gray Matter Loss in Relapsing-Remitting Multiple Sclerosis‏ ‎‡9 1‏
919 ‎‡a classicmyelinbasicproteinsareexpressedinlymphoidtissuemacrophages‏ ‎‡A "Classic" myelin basic proteins are expressed in lymphoid tissue macrophages‏ ‎‡9 1‏
919 ‎‡a bringingclaritytograymatteratrophy‏ ‎‡A Bringing CLARITY to gray matter atrophy‏ ‎‡9 1‏
919 ‎‡a cerebellarcorticalatrophyinexperimentalautoimmuneencephalomyelitis‏ ‎‡A Cerebellar cortical atrophy in experimental autoimmune encephalomyelitis.‏ ‎‡9 1‏
919 ‎‡a bedsidetobenchtobedsideresearchestrogenreceptorbetaligandasacandidateneuroprotectivetreatmentformultiplesclerosis‏ ‎‡A Bedside to bench to bedside research: Estrogen receptor beta ligand as a candidate neuroprotective treatment for multiple sclerosis‏ ‎‡9 1‏
919 ‎‡a multimodalmultidimensionalatlasofthec57bl6jmousebrain‏ ‎‡A A multimodal, multidimensional atlas of the C57BL/6J mouse brain‏ ‎‡9 1‏
919 ‎‡a enhancingimagequalityinclearedtissuewithadaptiveoptics‏ ‎‡A Enhancing image quality in cleared tissue with adaptive optics‏ ‎‡9 1‏
919 ‎‡a corticalatrophyinexperimentalautoimmuneencephalomyelitisinvivoimaging‏ ‎‡A Cortical atrophy in experimental autoimmune encephalomyelitis: in vivo imaging‏ ‎‡9 1‏
946 ‎‡a b‏ ‎‡9 1‏
996 ‎‡2 BIBSYS|7076492‏
996 ‎‡2 J9U|987007452478805171‏
996 ‎‡2 SIMACOB|109574755‏
996 ‎‡2 LC|no2019130674‏
996 ‎‡2 LC|n 2009022267‏
996 ‎‡2 NUKAT|n 2022070905‏
996 ‎‡2 ISNI|000000051251150X‏
996 ‎‡2 DNB|1016180861‏
996 ‎‡2 ISNI|000000038424264X‏
996 ‎‡2 ISNI|0000000025323464‏
996 ‎‡2 SUDOC|081445059‏
996 ‎‡2 PTBNP|1604613‏
996 ‎‡2 CAOONL|ncf10669406‏
996 ‎‡2 BIBSYS|90159137‏
996 ‎‡2 ISNI|0000000031005665‏
996 ‎‡2 RERO|A003313373‏
996 ‎‡2 RERO|A003313371‏
996 ‎‡2 DNB|1310227349‏
996 ‎‡2 RERO|A003313374‏
996 ‎‡2 ISNI|0000000353919347‏
996 ‎‡2 NSK|000527345‏
996 ‎‡2 BIBSYS|14039330‏
996 ‎‡2 BIBSYS|90504960‏
996 ‎‡2 PLWABN|9811261636405606‏
996 ‎‡2 BNF|18067120‏
996 ‎‡2 DNB|120668076‏
996 ‎‡2 ISNI|0000000026137217‏
996 ‎‡2 CAOONL|ncf10612751‏
996 ‎‡2 NUKAT|n 2022000908‏
996 ‎‡2 JPG|500229353‏
996 ‎‡2 LC|n 2004037667‏
996 ‎‡2 CAOONL|ncf10145893‏
996 ‎‡2 ISNI|0000000500605816‏
996 ‎‡2 J9U|987007280231505171‏
996 ‎‡2 NUKAT|n 2009127446‏
996 ‎‡2 J9U|987007312170205171‏
996 ‎‡2 BIBSYS|90893202‏
996 ‎‡2 BIBSYS|14003983‏
996 ‎‡2 NII|DA0071500X‏
996 ‎‡2 DNB|1016343078‏
996 ‎‡2 PTBNP|1178183‏
996 ‎‡2 LC|n 85198524‏
996 ‎‡2 ISNI|0000000451600938‏
996 ‎‡2 NLA|000035721188‏
996 ‎‡2 LC|no2023091167‏
996 ‎‡2 LC|n 81121739‏
996 ‎‡2 NTA|151057753‏
996 ‎‡2 ISNI|0000000119431642‏
996 ‎‡2 DNB|1042519730‏
996 ‎‡2 LC|nb2012013025‏
996 ‎‡2 LC|no 99046917‏
996 ‎‡2 J9U|987007451693005171‏
996 ‎‡2 NKC|jo2017942658‏
996 ‎‡2 LC|no 98064032‏
996 ‎‡2 SUDOC|056522371‏
996 ‎‡2 RERO|A005780366‏
996 ‎‡2 NTA|123829224‏
996 ‎‡2 N6I|vtls002581326‏
996 ‎‡2 BLBNB|000571043‏
996 ‎‡2 CAOONL|ncf11333389‏
996 ‎‡2 DNB|1089616112‏
996 ‎‡2 LC|no2003020248‏
996 ‎‡2 ISNI|0000000038000760‏
996 ‎‡2 ISNI|0000000067818182‏
996 ‎‡2 NKC|jx20101025004‏
996 ‎‡2 SUDOC|229386636‏
996 ‎‡2 LC|no 94016113‏
996 ‎‡2 ISNI|0000000499067749‏
996 ‎‡2 LC|n 93024341‏
996 ‎‡2 LC|n 94061649‏
996 ‎‡2 LC|n 2022007475‏
996 ‎‡2 JPG|500336240‏
996 ‎‡2 BIBSYS|3092793‏
996 ‎‡2 LC|no2018029914‏
996 ‎‡2 LC|n 89644171‏
996 ‎‡2 ISNI|0000000074110625‏
996 ‎‡2 CAOONL|ncf10978629‏
996 ‎‡2 LC|no2018157098‏
996 ‎‡2 RERO|A005541086‏
996 ‎‡2 ISNI|0000000109918641‏
996 ‎‡2 LC|nb2007013809‏
996 ‎‡2 CAOONL|ncf11262691‏
996 ‎‡2 LC|n 2023015897‏
996 ‎‡2 NTA|133966917‏
996 ‎‡2 LC|n 98802729‏
996 ‎‡2 PLWABN|9810702157105606‏
996 ‎‡2 J9U|987007364629305171‏
996 ‎‡2 ISNI|0000000043710097‏
996 ‎‡2 LC|no 95028145‏
996 ‎‡2 ISNI|0000000026720015‏
996 ‎‡2 PLWABN|9810539609405606‏
996 ‎‡2 SUDOC|052500993‏
996 ‎‡2 LC|no2010160965‏
996 ‎‡2 PTBNP|950950‏
996 ‎‡2 ISNI|0000000114586573‏
996 ‎‡2 PLWABN|9810607707705606‏
996 ‎‡2 J9U|987007344836805171‏
996 ‎‡2 ISNI|0000000069691250‏
996 ‎‡2 B2Q|0000410595‏
996 ‎‡2 PLWABN|9810680898405606‏
996 ‎‡2 ISNI|0000000485899675‏
996 ‎‡2 NII|DA02888982‏
996 ‎‡2 ISNI|000000002414734X‏
996 ‎‡2 LC|n 86804173‏
996 ‎‡2 BNF|14468102‏
996 ‎‡2 BNF|16274930‏
996 ‎‡2 ISNI|0000000074074329‏
996 ‎‡2 NUKAT|n 2015199903‏
996 ‎‡2 SUDOC|186375204‏
996 ‎‡2 LC|no2009019341‏
996 ‎‡2 CAOONL|ncf10405199‏
996 ‎‡2 JPG|500335225‏
996 ‎‡2 DNB|1228577668‏
996 ‎‡2 LC|n 87126139‏
996 ‎‡2 BIBSYS|1017274‏
996 ‎‡2 NUKAT|n 2008146342‏
996 ‎‡2 LC|n 87124908‏
996 ‎‡2 ISNI|0000000510854015‏
996 ‎‡2 NTA|331275678‏
996 ‎‡2 CAOONL|ncf10858527‏
996 ‎‡2 BIBSYS|90065546‏
996 ‎‡2 LC|nb 98027057‏
996 ‎‡2 CAOONL|ncf10022000‏
996 ‎‡2 LC|n 85132772‏
996 ‎‡2 ISNI|0000000059092721‏
996 ‎‡2 NUKAT|n 97024233‏
996 ‎‡2 ISNI|0000000074785008‏
996 ‎‡2 NUKAT|n 2010172790‏
996 ‎‡2 J9U|987007457542205171‏
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏